Macquarie Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Macquarie Group’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-18,675	Closed	-$998K	–	1714
2016 Q1	$998K	Sell	18,675 -6,330	-25%	-$467K	﹤0.01%	1120
2015 Q4	$2.83M	Buy	25,005 +1,530	+7%	+$169K	0.01%	845
2015 Q3	$2.76M	Sell	23,475 -17,378	-43%	-$2.27M	0.01%	895
2015 Q2	$3.16M	Sell	40,853 -1,304	-3%	-$85.5K	0.01%	895
2015 Q1	$2.44M	Sell	42,157 -18,975	-31%	-$806K	﹤0.01%	970
2014 Q4	$1.97M	Sell	61,132 -2,829	-4%	-$84.9K	﹤0.01%	1023
2014 Q3	$1.56M	Buy	+63,961	New	+$1.3M	﹤0.01%	1078

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Macquarie Group's ANAC Position: Q2 2016 in Review

Macquarie Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 18,675 shares — an estimated $998K sold.

Macquarie Group first reported a position in ANAC in Q3 2014 and held it in 7 quarters. The position peaked at $3.16M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Macquarie Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Macquarie Group sold 18,675 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $998K.
Macquarie Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 7 quarters.
Macquarie Group's ANACOR PHARMACEUTICALS INC COM position peaked at $3.16M in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Macquarie Group's 13F filing for Q2 2016, filed 15 Aug 2016.